Â鶹ԼÅÄ

Program - Montreal Cholesterol Summit

    Thursday, May 30, 2019

    RI MUHC - 1001 Decarie Blvd, Montreal, Quebec H4A 3J1

    12:00 - 12:45                

    Registration & lunch
    Location: RI MUHC Atrium - ES1

    Session 1 Co-Chairs : Michael Gagnon, MD & Guillaume Lepage-Mireault, MD
    Location: RI MUHC - ES1.1129 - Drs. Sylvia & Richard Cruess Amphitheatre
    12:45 - 1:00 Opening Remarks
    Sophie Bernard, MD
    Director, Lipids, Nutrition and Cardiovascular Prevention Clinic, Montreal Clinical Research Institute (IRCM)
    Assistant Professor, Department of Medicine, Faculty of Medicine, Université de Montréal
    1:00 - 1:45

    PCSK9: from Discovery to Therapeutic Applications

    Nabil G. Seidah, PhD, OQ, MRSC, MC
    Director, Laboratory, Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM)
    Professor, Departments of Medicine & Biochemistry, University of Montreal
    Adjunct Professor, Department of Medicine, Division of Experimental Medicine, Â鶹ԼÅÄ

    PDF icon nabil_seidah_presentation.pdf

    1:45 - 2:30

    Clinical Trials of PCSK9 Inhibitors for the Prevention of ASCVD

    Shaun Goodman, MD, MSc, FRCPC, FACC, FAHA, FESC, FCCS
    Adjunct Professor, Department of Medicine, Co-Director, Canadian VIGOUR Centre, University of Alberta
    Associate Head, Division of Cardiology, St. Michael's Hospital, Professor and Heart & Stroke Foundation of Ontario (Polo)
    Chair, Department of Medicine, University of Toronto

    PDF icon shaun_goodman_presentation.pdf

    2:30 - 3:15

    Canadian Guidelines for the Treatment of Dyslipidemias

    George Thanassoulis, MD, MSc, FRCP(C)
    Director, Preventive and Genomic Cardiology
    FSQ-S Clinician-Scientist
    Associate Professor, Department of Medicine, Â鶹ԼÅÄ

    PDF icon george_thanassoulis_presentation.pdf

    3:15 - 3:30 Break
    Location: RI MUHC Atrium - ES1
    Session 2 Chair: Latifah Alothman, MD
    Location: RI MUHC - ES1.1129 - Drs. Sylvia & Richard Cruess Amphitheatre
    3:30 - 4:15

    The Genetics of Familial Hypercholesterolemia (FH)

    Jean-Baptiste Rivière, PhD 
    Associate Investigator, RI-MUHC, Glen site
    Child Health and Human Development Program
    Assistant Professor, Department of Human Genetics, Faculty of Medicine, Â鶹ԼÅÄ

    PDF icon jean_baptiste_riviere_presentation.pdf

    4:15 - 5:00

    The Implications of Genetic Diagnosis

    Yann Joly, PhD, FCAHS, Ad.E.
    Research Director, Centre of Genomics and Policy
    Associate Professor, Department of Human Genetics, Â鶹ԼÅÄ

    PDF icon yann_joly_presentation.pdf

    5:00-5:30

    Discussion and Public Forum
    Jacques Genest, MD, FRCP(C)
    Professor, Department of Medicine, Â鶹ԼÅÄ
    Research Institute of the Â鶹ԼÅÄ Health Centre

    Back to top